PenderFund Capital Management Ltd. Takes Position in Addus HomeCare Corporation $ADUS

PenderFund Capital Management Ltd. acquired a new stake in Addus HomeCare Corporation (NASDAQ:ADUSFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 18,497 shares of the company’s stock, valued at approximately $1,858,000.

A number of other hedge funds also recently added to or reduced their stakes in the business. Oregon Public Employees Retirement Fund grew its holdings in Addus HomeCare by 2.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after acquiring an additional 103 shares in the last quarter. ProShare Advisors LLC raised its position in shares of Addus HomeCare by 3.1% in the 4th quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock worth $379,000 after acquiring an additional 105 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in shares of Addus HomeCare by 0.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock worth $2,150,000 after purchasing an additional 106 shares during the last quarter. State of Wyoming boosted its position in Addus HomeCare by 25.7% during the fourth quarter. State of Wyoming now owns 523 shares of the company’s stock valued at $56,000 after purchasing an additional 107 shares in the last quarter. Finally, Pathstone Holdings LLC boosted its position in Addus HomeCare by 0.9% during the third quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock valued at $1,502,000 after purchasing an additional 112 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Trading Down 2.2%

Shares of Addus HomeCare stock opened at $118.01 on Friday. The firm’s 50 day simple moving average is $111.53 and its two-hundred day simple moving average is $102.87. The firm has a market capitalization of $2.20 billion, a price-to-earnings ratio of 20.70, a PEG ratio of 1.62 and a beta of 0.87. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.70 by $0.03. The business had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.49 earnings per share. Analysts predict that Addus HomeCare Corporation will post 6.3 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Barclays raised their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $130.88.

Get Our Latest Stock Analysis on Addus HomeCare

Insider Transactions at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by company insiders.

Addus HomeCare Profile

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.